Article Versions Notes

Hirano Y, Shinya Y, Aono T, Hasegawa H, Kawashima M, Shin M, Takami H, Takayanagi S, Umekawa M, Ikemura M, et al. The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions. Current Oncology. 2022; 29(7):4558-4565. https://doi.org/10.3390/curroncol29070360

Hirano, Yudai, Yuki Shinya, Toshiya Aono, Hirotaka Hasegawa, Mariko Kawashima, Masahiro Shin, Hirokazu Takami, Shunsaku Takayanagi, Motoyuki Umekawa, Masako Ikemura, and et al. 2022. "The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions" Current Oncology 29, no. 7: 4558-4565. https://doi.org/10.3390/curroncol29070360

Hirano, Y., Shinya, Y., Aono, T., Hasegawa, H., Kawashima, M., Shin, M., Takami, H., Takayanagi, S., Umekawa, M., Ikemura, M., Ushiku, T., Taoka, K., Tanaka, S., & Saito, N. (2022). The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions. Current Oncology, 29(7), 4558-4565. https://doi.org/10.3390/curroncol29070360